Pediatric Health Care Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
Pediatric Health Care Products and Services Market: Overview Pediatric healthcare products and services include medical care of children, adolescents and infants. The healthcare condition of children can be categorized into short term and chronic illness. Short term illnesses are transient in nature and require significant primary care of child during the diseased condition. These illnesses can treat and cure within 1-5 days. Chronic illnesses are more serious and generally demand more amount of money for the treatment. The market of pediatric healthcare products and services market can be segmented as follows: By Types Short term illness (such as ear infection, upper respiratory infection and others) Chronic illness (such as cystic fibrosis, diabetes, malnutrition and others) Increasing population using pediatric healthcare products and services will drive the growth of this market. In addition, increasing number of cases of diarrhea, malnutrition and other disorders in children will demand utilization of pediatric products and services hence stimulates the market growth. Browse Global Strategic Business Report: http://www.transparencymarketresearch.com/pediatric-health-care-products-servicesmarket.html Pediatric Health Care Products and Services Market: Trends and Drivers According to United Nations Children's Fund (UNICEF), there are 195 million children (less than 5 five years of age) affected by malnutrition every year. Thus, increasing cases of malnutrition in pediatric population propels the uptake of pediatric healthcare products and services and drives the market growth. Additionally, consistent efforts of key players to introduce safe and effective feeding methods for pediatric patients will further accentuate the growth of this market. For example, CORPAK Medsystems, Inc., in collaboration with Baxa Corporation and Premier, Inc. developed CORFLO Anti-IV Enteral Feeding Tube and Baxa Exacta-Med Anti-IV enteral syringe. These devices are